ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹227 Cr | ₹8357 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 0.51% | -0.21% |
6 Month | 9.91% | 10.3% |
1 Year | -3.67% | -1.03% |
3 Year | 22.03% | 23.87% |
5 Year | - | 18.01% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 1.94% | 2.85% |
1 Year | 3.79% | 8% |
3 Year | 19.77% | 21.14% |
5 Year | - | 18.27% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 19.5% | 17.31% |
3 Year | 19.53% | 20.52% |
5 Year | - | 20.64% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.57% | 15.03% |
Sharp | 0.86% | 1.00% |
Beta | 0.95% | 0.91% |
Alpha | -2.07% | 0.32% |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 4.23 | 1.56 |
Large Cap | 29.73 | 34.91 |
Mid Cap | 37.1 | 32.08 |
Small Cap | 28.95 | 31.46 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 2.13 | 0.52 |
Healthcare | 90.65 | 99.48 |
Basic Materials | 3.99 | - |
Industrials | 1.99 | - |
Financial Services | 1.24 | - |
Top Comparisons
ICICI Prudential All Seasons Bond Fund - Growth
3Y Returns7.7%
Aditya Birla Sun Life Dynamic Bond Fund - Growth - Regular Plan
3Y Returns7.51%
ICICI Prudential Commodities Fund - Growth Option
3Y Returns18.87%
UTI-Transpotation and Logistics Fund-Growth Option
3Y Returns23.66%
BANDHAN MULTI CAP FUND - GROWTH - REGULAR PLAN
3Y Returns18.06%
Baroda BNP Paribas MULTI CAP FUND - Regular Plan - Growth Option
3Y Returns19.5%
Aditya Birla Sun Life Liquid Fund-Institutional (Growth)
3Y Returns7.01%
Mirae Asset Liquid Fund - Growth
3Y Returns6.98%